Gastrointestinal Manifestations Among Patients With COVID19

Gastrointestinal Manifestations in COVID-19: Symptoms and Signs and Its Impact on the Outcome

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04544150

Enrollment

220

Registered

2020-09-10

Start date

2020-06-01

Completion date

2020-09-01

Last updated

2020-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

many patients with confirmed infection with COVID-19 suffer from different symptoms and signs of gastrointestinal symptoms

Detailed description

many patients with COVID1-9 infection experienced many intestinal symptoms mainly abdominal pain, vomiting, and diarrhea. This study aimed to assess the frequency of GIT manifestations among patients with COVID-19 and its impact on the outcome

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* all patients with COVID19

Exclusion criteria

* patient refusal to participate in the study

Design outcomes

Primary

Measure	Time frame	Description
frequency of GIT symptoms among patients with COVID-19 infection	Baseline	any GIT symptoms in such patients were recorded

Countries

Egypt

Outcome results